Clonazepam in Pregnancy: Risks, Alternatives & Management

Clonazepam (benzodiazepine) is generally avoided in pregnancy (FDA Category D — positive evidence of risk).

Risks

  • First trimester: Cleft lip/palate, cardiac defects (conflicting data; absolute risk low but present).
  • Third trimester: Neonatal floppy infant syndrome (hypotonia, hypothermia, feeding difficulty, respiratory depression), withdrawal (irritability, tremor, seizures).
  • Breastfeeding: Excreted in milk; infant sedation, poor feeding.

If Benefits Outweigh Risks (Rare)

  • Severe refractory epilepsy or panic disorder unresponsive to safer alternatives.
  • Lowest effective dose, shortest duration.
  • Folic acid 4 mg/day (neural tube protection).
  • Serial ultrasounds (anatomy, growth).
  • Neonatal monitoring ≥72 hrs for withdrawal.
  • Avoid 3rd trimester if possible.

Preferred Alternatives

  • Seizures: Lamotrigine, levetiracetam (pregnancy registries favorable).
  • Anxiety: Sertraline, escitalopram (SSRIs first-line); CBT.
  • Insomnia: CBT-I, sleep hygiene.

Never stop abruptly — taper under supervision. Preconception planning ideal.

Pregnancy & Health - Related Articles